Chiu, D. K., Zhang, X., Cheng, B. Y., Liu, Q., Hayashi, K., Yu, B., . . . Engleman, E. G. (2025). Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity. Science, 388(6745), 1. https://doi.org/10.1126/science.adr3026
Chicago Style (17th ed.) CitationChiu, David Kung-Chun, et al. "Tumor-derived Erythropoietin Acts as an Immunosuppressive Switch in Cancer Immunity." Science 388, no. 6745 (2025): 1. https://doi.org/10.1126/science.adr3026.
MLA (9th ed.) CitationChiu, David Kung-Chun, et al. "Tumor-derived Erythropoietin Acts as an Immunosuppressive Switch in Cancer Immunity." Science, vol. 388, no. 6745, 2025, p. 1, https://doi.org/10.1126/science.adr3026.
Warning: These citations may not always be 100% accurate.